Matthias Gehringer

Eberhard Karls Universität Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

Stefan Knapp

Goethe University Frankfurt

GERMANY

View details

Andrew Murkin

Associate Professor

University at Buffalo - North Campus

UNITED STATES

View details

Michael Laemmerhofer

Prof

Eberhard Karls Universität Tübingen

GERMANY

View details

Ricardo Augusto Massarico Serafim

Eberhard Karls Universität Tübingen

GERMANY

View details

Thierry Langer

Universität Wien

AUSTRIA

View details

Florian Wittlinger

Eberhard Karls Universität Tübingen

GERMANY

View details

Chiara Borsari

L'Oréal-UNESCO Fellow and Adjunct Professor

University of Milan

ITALY

View details

Frank Boeckler

University Professor (W3) for Medicinal Chemistry / Drug Design

Eberhard Karls Universität Tübingen

GERMANY

View details

Alexander Titz

Professor of Organic and Pharmaceutical Chemistry

Saarland University

GERMANY

View details

Jon Elkins

University of Oxford

UNITED KINGDOM

View details

Gerd Pluschke

Swiss Tropical and Public Health Institute

SWITZERLAND

View details

David Heppner

Assistant Professor

University at Buffalo

UNITED STATES

View details

Manfred Jung

Professor for Pharmaceutical Chemistry, www.jungm.de

University of Freiburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Gehringer

Research Interests

Explore related searches

Contact this professor

Articles (18)

Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S<sub>N</sub>Ar Electrophiles

Demystifying Functional Parameters for Irreversible Enzyme Inhibitors

Journal of Medicinal Chemistry Collection: Drug Discovery in Germany

Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

We are MedChem: The Frontiers in Medicinal Chemistry 2024

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

Targeting Lewy body dementia with neflamapimod‐rasagiline hybrids

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond

Back in Person: Frontiers in Medicinal Chemistry 2023

Covalent chemical probes for protein kinases

Frontiers in Medicinal Chemistry 2022 Goes Virtual

Chemical Probes for Understudied Kinases: Challenges and Opportunities

Publication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?

Never Gonna Give You Up – Current Developments in Covalent Protein Kinase Inhibitors

Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer

Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor

An Antigen Capture Assay for the Detection of Mycolactone, the Polyketide Toxin of Mycobacterium ulcerans

Discovery of a Potent and Highly Isoform-Selective Inhibitor of the Neglected Ribosomal Protein S6 Kinase Beta 2 (S6K2)

Collaborators (13)

Stefan Knapp

Andrew Murkin

Michael Laemmerhofer

Ricardo Augusto Massarico Serafim

Thierry Langer

Florian Wittlinger

Chiara Borsari

Frank Boeckler

Alexander Titz

Jon Elkins

Gerd Pluschke

David Heppner

Manfred Jung

Make your next move.